Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Niaspan clinical activity reported at atherosclerosis symposium

Oct. 16, 1997

Lipogelosomes: a novel approach to lowering cholesterol

Oct. 16, 1997

Preclinical cholesterol-lowering efficacy described for FR-194738

Oct. 16, 1997

Fujisawa's benzimidazole derivatives have broad therapeutic potential

Oct. 15, 1997

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

Sensus reports early clinical results with B2036-PEG

Oct. 15, 1997

Yamanouchi files for approval of hypoglycemic agent

Oct. 15, 1997

Safety and pharmacokinetics of new hyperlipidemia Rx in humans

Oct. 15, 1997

Bristol-Myers Squibb and Karo Bio to codevelop new therapies for metabolic disorders

Oct. 15, 1997

Nonthiazolidinediones for diabetes and obesity described by Merck & Co.

Oct. 14, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...